BioInsights - Preclinical & translational R&D - spotlight

CELL & GENE THERAPY INSIGHTS

Preclinical & translational R&D

Sven Kili
Guest Editor:
Sven Kili, CEO at Antion Biosciences
February 2023
Preclinical & translational R&D
Download PDF

Interview

Navigating the path to clinic for ATMPs: a regulator’s perspective

Navigating the path to clinic for ATMPs: a regulator’s perspective

James W McBlane
2 February 2023
Read
Preclinical toolkit evolution for cancer vaccines & CAR-T cell therapy

Preclinical toolkit evolution for cancer vaccines & CAR-T cell therapy

Adam Snook
18 January 2023
Read

Viewpoint

Preclinical safety assessment in therapeutic genome editing

Preclinical safety assessment in therapeutic genome editing

Roberto Nitsch
10 March 2023
Read
Addressing gene therapy translational R&D bottlenecks in the CNS

Addressing gene therapy translational R&D bottlenecks in the CNS

Anindya Sen
9 March 2023
Read
Key considerations when translating a cell therapy product into the clinic

Key considerations when translating a cell therapy product into the clinic

Anthony Ting
6 February 2023
Read